Table 4 |
||||||
|
Risk of Fall in Occasional and Regular Users of Inappropriate Medication compared to Never Users |
||||||
|
≤ 1 fall |
≥ 2 falls |
|||||
|
Medication n (%) |
(N = 4961) |
(N = 1382) |
OR (95% CI) |
crude P-Value |
OR (95% CI)*† |
P-Value† |
|
|
||||||
|
Inappropriate medication full list |
||||||
|
Occasional user‡ |
809 (16) |
277 (20) |
1.48 (1.26–1.74) |
<.001 |
1.23 (1.04–1.45) |
.016 |
|
Regular user § |
1389 (28) |
465 (34) |
1.45 (1.26–1.66) |
<.001 |
1.08 (0.94–1.25) |
.29 |
|
Inappropriate medication without cerebral vasodilators |
||||||
|
Occasional user |
704 (14) |
239 (17) |
1.38 (1.17–1.63) |
<.001 |
1.22 (1.02–1.45) |
.030 |
|
Regular user |
826 (17) |
300 (22) |
1.48 (1.27–1.72) |
<.001 |
1.19 (1.00–1.41) |
.049 |
|
Long-acting benzodiazepines |
||||||
|
Occasional user |
286 (9) |
117 (13) |
1.58 (1.26–1.98) |
<.001 |
1.40 (1.10–1.79) |
.006 |
|
Regular user |
316 (9) |
135 (15) |
1.65 (1.33–2.04) |
<.001 |
1.41 (1.12–1.79) |
.004 |
|
Inappropriate psychotropic drugs |
||||||
|
Occasional user |
102 (2) |
37 (3) |
1.33 (0.91–1.95) |
.14 |
1.17 (0.74–1.83) |
.50 |
|
Regular user |
74 (1) |
39 (3) |
1.93 (1.30–2.86) |
.001 |
1.74 (1.14–2.66) |
.010 |
|
Inappropriate medication with anticholinergic properties |
||||||
|
Occasional user |
264 (5) |
91 (7) |
1.29 (1.01–1.65) |
.042 |
1.21 (0.93–1.58) |
.15 |
|
Regular user |
172 (3) |
84 (6) |
1.83 (1.40–2.40) |
<.001 |
1.57 (1.18–2.10) |
.002 |
|
Short- or intermediate-half-life benzodiazepines |
||||||
|
Occasional user |
429 (9) |
151 (11) |
1.34 (1.10–1.63) |
.004 |
1.20 (0.96–1.49) |
.11 |
|
Regular user |
441 (9) |
153 (11) |
1.32 (1.08–1.60) |
.006 |
1.05 (0.83–1.32) |
.69 |
|
|
||||||
|
* Reference group: Never user of inappropriate medication ‡ Occasional user: exposure at only one of the 3 examinations (baseline and 2 follow-up) §Regular user: exposure at two or three examinations † Adjusted for age, sex, study centre, Body Mass Index, diurnal drowsiness, number of drugs (excluding IM), cognitive functioning, depressive symptoms and impaired mobility. |
||||||
|
Berdot et al. BMC Geriatrics 2009 9:30 doi:10.1186/1471-2318-9-30 |
||||||